Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.40 |
| ▸ | ACACB | O00763 | 7/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.36 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.35 |
| ▸ | RARA | P10276 | 1/20 | 0.33 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | RARG | P13631 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9512290 | 0.97 | FFAR1 (0.39) | FFAR1ACACBCYP2A6AAK1TUBB1 | |
| SCHEMBL9508905 | 0.88 | FFAR1 (0.44) | FFAR1ACACBAAK1 | |
| SCHEMBL7857744 | 0.88 | FFAR1 (0.44) | FFAR1ACACBAAK1 | |
| SCHEMBL9508737 | 0.88 | CYP2A6 (0.37) | FFAR1ACACBCYP2A6 | |
| SCHEMBL9509124 | 0.86 | FFAR1 (0.42) | FFAR1ACACB | |
| SCHEMBL9511390 | 0.86 | FFAR1 (0.42) | FFAR1ACACBAAK1 | |
| SCHEMBL9509292 | 0.85 | RXRA (0.35) | ACACBCYP2A6 | |
| SCHEMBL9510153 | 0.85 | HSD17B10 (0.43) | FFAR1RARARARBRARGRAB9A | |
| SCHEMBL9511350 | 0.84 | ACACB (0.38) | ACACBCYP2A6 | |
| SCHEMBL9512554 | 0.84 | HSD17B10 (0.46) | FFAR1RARARARBRARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0308438-B1 | LIQUID CRYSTAL PHASE CONTAINING TOLANES | MERCK PATENT GmbH (DE) | 1993-09-29 | — | — | EP | disclosed |